Cipla kundali

Cipla (CIPLA, Healthcare) was incorporated on 17 August 1935. This page shows its birth chart, its dasha periods since listing and how the share moved in each.

Cipla birth chart

Lagna Kanya, lagna lord Budh in the 12th house. Moon in Meena, Uttara Bhadrapada pada 2.

Cipla's chart: strong leadership, a strained house of gains

A patient pharma house built to compound slowly

Cipla's chart describes a company that earns through steady work, not noise. It makes medicines, keeps debt almost nil and grows over decades. The share record shows it: from Rs 9.3 in November 1996 to Rs 1,392 today, a rise of 14,897%. It also shows long dull patches. In Rahu's years from 2014 the share often trailed the Nifty.

The one idea this reading keeps returning to is that Cipla does best when its own work leads, and worst when outside pressure, leadership change or a restless phase dominates. The strong planets in the chart favour disciplined effort. The weak spots sit in gains and in how the top team holds together.

This reading follows the company from 17 August 1935, the date of incorporation the chart is cast for, to today, period by period. It looks only at what has already happened. Where the share went against the chart, it says so.

Strong in work and leadership, tested in gains and assets

Cipla's chart is cast for its incorporation on 17 August 1935. The hour is not on record, so the houses are indicative, while the Moon and the dashas are firm.

The first placement is the house of work and career, which holds the strongest sign in the chart. Budh, the planet of trade and intellect, rules it and sits with Surya, the Sun, in the house of loss and distant lands. This suits a company that earns abroad. Cipla sells in India, the United States and South Africa, and it keeps adding overseas partnerships. On 3 September 2026 it announced a US licensing and supply deal with Qilu Pharmaceutical for a biosimilar to Keytruda. On 31 August 2026 it signed a licence with SBP Group for a HER2 bispecific ADC.

The second placement is Shani, the planet of discipline, in the house of debt and disputes. Shani is strong there. This is why Cipla handles strain well. Debt is only 0.01 times equity, and operating profit covers interest 68.9 times. The company holds ₹1,837 crore more cash than debt. Its financial strength is rated safe. Shani also brings regulatory attention, and you see it in the USFDA inspections at InvaGen in New York and at Pithampur in India during August and October 2026.

The third placement is weaker. Guru, the planet of expansion, is the weakest planet in the chart and sits in the house of income. The Moon also sits in the house of partnerships, the weakest part of the chart. Together they explain why results do not always match the size of the business. Revenue is down 2.4% and profit down 35.1% on the year to 30 September 2026, while the median healthcare company grew 22.5% and 15.3%. Return on equity is 8.2% against 12.2% for peers.

The fourth placement is Rahu, the shadow planet of sudden change, in the house of property and foundations. Ketu, its opposite, sits in the house of leadership. This pairing gives the company a pattern of top-level turnover. The chief financial officer left in 2022 and the managing director and CEO, Umang Vohra, resigned with effect from 1 April 2026. The company filed 14 management change notices in the past year. Cash is a bright spot here: operating cash is 1.02 times reported profit, and customers pay in about 78 days.

In short, the chart shows a company with a strong business base, firm discipline on debt and a steady reach abroad. Its recurring weak spots are slower income growth and frequent changes at the top.

Surya's year: Cipla's first full year on record rewards early holders

The Sun major period ran only about a year, from December 1996 to December 1997, and it is the opening chapter of the price record we hold. In that time the share rose 27%. It also fell 27% at its worst point inside the year, so the gain came with a rough ride. No acquisition, bonus, merger or management exit is on record in these months, so the move was the market's own verdict on a settled pharma business.

The chart reason is simple. Surya, the Sun, sits in the twelfth house of this chart, the house of overseas links, spending and quiet losses. It is in its own favoured sign, Simha, and is among the two strongest planets in the chart. A strong planet in a house of outflow gives a period that builds slowly and pays for it with swings rather than one that races ahead.

For someone who owns Cipla today, the lesson is about temperament. Even in its earliest recorded year, this company rewarded patience but did not spare its holders a sharp dip along the way. That pattern of steady gain with deep pauses repeats through later periods.

Shukra's sub-period: a 27% rise, with a 27% scare inside

From December 1996 to December 1997 the share rose 27%. At its worst point inside that year it was down 27%, so anyone who held through the fall saw the whole gain arrive in the second half. There are no company events on record in these months, so the movement belongs to the share's own rhythm and not to a deal or a boardroom change. Nifty comparison figures do not exist for this early stretch.

The reason lies with Shukra, Venus, the lord of this sub-period. In this chart Shukra rules the second house of income and the ninth house of fortune, which are both good houses for a company's earnings. But it sits in the twelfth house, in a sign it does not like, so the reward comes with leakage. That fits a year of real gain and a heavy mid-year drop.

What this tells an investor is that Cipla's early compounding was never smooth. The chart gave it a good source of income and a weak place to hold it. The gain was real, but only for those who sat through a drawdown as large as the final profit. The chart read this stretch correctly: a good result, bought at the price of discomfort.

Moon years: Cipla's decade of eleven-fold growth

The Moon major period, from December 1997 to December 2007, was the great compounding decade of Cipla's listed life. The share rose 1,136% across it, from a company still finding its footing to one valued as a leading Indian drug maker. It was not smooth. Falls of 26%, 61%, 42%, 32% and 36% came inside individual stretches, and the share still ended far higher.

The reason is simple. Chandra, the Moon, rules the house of gains in this chart, the 11th, and sits in the 7th house of partners, customers and markets. A period under the Moon rewards what the company earns from the outside world. The hour of incorporation is not on record, so the houses are indicative while the Moon and the dashas are firm.

For an investor the lesson is that Cipla's best returns came in long, patient climbs with sharp setbacks on the way. Only one sub-period, Moon–Sun, ended lower, and that by just 5%. Nine sub-periods follow, each with a different cause and a different character.

A fast 53% start with a 26% scare

From December 1997 to October 1998 the share rose 53%. That was a strong opening to the decade. Inside the period it fell 26% at its worst point, so holders had to sit through a real scare before the gain arrived. No Nifty comparison is on record for these years.

The reason is that this was the Moon's own sub-period. Chandra rules the 11th house of gains and sits in the 7th house of customers and markets, so the period speaks for the demand the company meets. The share's early rise fits that reading.

The company's own published results are not on file for these years, so the business side cannot be put in figures. What the stretch tells an investor is that Cipla could rise quickly when its market opened up, but that the first rush brought a deep dip. The gain was real, and so was the volatility that came with it.

Mars lifts the share 48% in seven months

From October 1998 to May 1999 the share rose 48% in a short span. The sharpest single day of the stretch came on 1 March 1999, when it jumped 15%. No fall inside the period is recorded, so this was a clean run.

Mangal, Mars, is the planet of drive and effort. In this chart it rules the 3rd house of initiative and the 8th house of sudden change, and it sits in the 2nd house of wealth. That mix explains a burst of energy that came quickly and showed up in the price within days.

The lesson for an investor is that Cipla's moves can be sudden. A single 15% day shows how quickly sentiment can turn in this name. Such bursts also tend to be followed by tests, and the next stretch, under Rahu, was the most violent of the decade.

Rahu doubles the share, then takes back 61%

From May 1999 to November 2000 the share rose 127%, the biggest gain of the decade. But it also fell 61% at its worst point inside the period. The sharpest day came on 23 May 2000, when the share dropped 11%. The calendar year 1999 gave a 374% gain, while 2000 ended 22% lower.

Rahu is a shadow planet that magnifies whatever it touches, and it sits in the 4th house of assets and foundations in this chart. It owns no house, so it acts through Guru, its dispositor. The result is extremes, with sharp climbs and sharp collapses side by side.

For an investor this is the clearest warning in the decade. Cipla can reward patience handsomely, but in a Rahu stretch the path is violent. A reader who held through the 61% fall was paid, but only by surviving it.

Guru years: the share barely moves, up 4%

From November 2000 to March 2002 the share rose just 4%. After the huge swings of the Rahu stretch, this was a quiet pause. The calendar year 2001 ended 9% higher, so there was a small gain but no breakout.

Guru, Jupiter, is the planet of expansion, yet in this chart it sits in an enemy sign in the 2nd house and is the weakest planet. It rules the 4th house of assets and the 7th of partners. A weak Guru gives little lift, so growth stalled even as the business carried on.

The lesson is that Cipla does not rise every year. After a boom and a bust, the share rested for fifteen months. An investor who bought at the Rahu-era peak found that time, not price, did the healing. No filing in this window is on record to show a business cause.

Shani years: 5% gain after a 42% slide

From March 2002 to October 2003 the share rose only 5%, but the path was rough. At its worst it was down 42%, and on 28 April 2003 it lost 11% in a single day. The calendar year 2002 fell 20%, while 2003 recovered with a 37% gain.

Shani, Saturn, is the planet of discipline and delay. It rules the 5th house of skill and the 6th house of competition and debt, and it sits strongly in the 6th itself. Such a period tests a company through rivals and pressure, and it rewards survival. The first year was the test and the second was the reward.

For an investor, the picture is that Cipla took a heavy blow and then rebuilt. The end figure of 5% hides a deep drawdown and a sharp recovery. This was a stretch that punished weak hands and paid those who waited.

Budh years: steady 23% with a 32% dip

From October 2003 to March 2005 the share rose 23%, with a 32% fall at its worst point. The calendar year 2004 added 19%. It was a measured climb, quieter than the Rahu years and far gentler than the Shani slide before it.

Budh, Mercury, is the planet of trade and commerce. He is the lord of the 1st house of the company's identity and the 10th house of its work and standing, and he is the chart's strongest planet. That is why this stretch rewarded ordinary business progress without drama.

The lesson is that when Budh leads, Cipla grows on its trading strength, not on excitement. A 23% gain over seventeen months is modest, but it came after the 42% slide, so it rebuilt confidence. No company filing is on record for this window.

Ketu's short spell adds 30% in seven months

From March 2005 to October 2005 the share rose 30%, with no fall recorded inside the period. The calendar year 2005 ended 42% higher. This was a short, clean climb of a kind the decade rarely gave.

Ketu is a shadow planet of detachment and release. In this chart it sits in the 10th house of work and standing, and it acts through Guru and Budh. That placement can shed old weight from the company's work, which fits a period of quiet progress without the usual setbacks.

For an investor the stretch shows Cipla at its most efficient: a steady business, no scare and a strong return in a few months. It was also the calm before the busier Venus years, which brought a bonus issue. No filings are on record inside this window.

Shukra years: 45% gain, a bonus, and a 14% shock

From October 2005 to June 2007 the share rose 45%, though it fell 36% at its worst point. On 24 April 2006 the company issued bonus shares in the ratio of 3:2. The share jumped 11% on 2 February 2006, then lost 14% on 27 April 2007. The calendar year 2006 rose 41%, while 2007 ended lower.

Shukra, Venus, is the planet of comfort and money. It rules the 2nd house of wealth and the 9th of fortune, yet it sits in an enemy sign in the 12th house of losses. That is why rewards came with sharp reversals. The bonus is a clear sign of the 2nd house of wealth delivering.

For an investor, this stretch shows Cipla sharing its gains with shareholders while the market swung hard around them. A 45% gain in twenty months was good, but a 36% drop on the way was the price of staying invested.

Surya's last half-year: share slips 5%

From June 2007 to December 2007 the share fell 5%, the only weak sub-period of the whole decade. The calendar year 2007 ended 14.5% lower. After ten years of compounding, the Moon period closed with a pause.

Surya, the Sun, is the planet of authority and status. It rules the 12th house of expenses and losses and sits there in its own sign, the moolatrikona. It is strong, but it points the period toward outflow and consolidation, so the market gave back some ground.

The lesson is mild. The only losing stretch was small, and it came after a 1,136% decade. It fits a company taking a breath before the next major period, under Mars, where it began beating the Nifty in most stretches. No filings are on record for this half-year.

Mars years: Cipla beat the market through 2014

The Mars major period ran from December 2007 to December 2014. The share rose 239% over these seven years and beat the Nifty in most of the sub-periods. It was a steady climb with two flat patches, not a straight line.

The chart reason is simple. Mangal, the planet of drive and effort, rules the 3rd house of initiative and the 8th house of sudden change in this chart. It sits in the 2nd house of income. So effort turned into earnings, while upheavals at the top and in the business arrived in jolts.

A small gain while the Nifty fell 14%

From December 2007 to May 2008 the share rose 10%, while the Nifty fell about 14%. No company event is recorded inside these five months. The share held up when the wider market was sinking.

The reason is that Mangal's own sub-period lets the major lord act directly. Mangal rules the 3rd house of effort and the 8th of sudden change, and sits in the house of income. Cipla's 17% operating margin today shows that earning habit is still there.

For an investor, the lesson is that this company tends to act as a shelter when the broad market is under pressure. The gain was modest, but it was earned in a falling market. That pattern of resilience is part of its character.

Rahu's year: gains in a market down 18%

Between May 2008 and May 2009 the share rose 4% while the Nifty fell 18%. Inside the year it dropped 33% at its worst point. On 19 May 2009 it fell 10% in one day, the sharpest move of the period.

Rahu, the planet of sudden swings and the unfamiliar, sits in the 4th house of assets and stability. It breeds restlessness there, so the ride was rough even though the finish was positive. The chart explains the volatility well.

The lesson for an owner is that Cipla can fall hard inside a year and still end it ahead. The deep drop was a test of nerve, not a lasting loss. Today's debt of only 0.01 times equity shows the balance sheet has stayed built for such storms.

Guru's year: Cipla more than doubled the Nifty

From May 2009 to May 2010 the share rose 55%, against 25% for the Nifty. No fall worth noting is recorded inside the period, and there were no major events until the very end. It was the cleanest stretch of the whole Mars era.

Guru, the planet of expansion, rules the 4th house of assets and the 7th of partnerships. Yet it sits in an enemy sign in the house of income, so its help comes through steady business rather than easy luck. Guru is the chart's weakest planet, and still this window delivered.

For an investor this shows that Cipla rewards patience in a recovering market. It did better than the index by a wide margin, mostly because of earnings power and not from a single deal. The assets side still shows in operating cash at 1.02 times profit.

Shani's year: an acquisition, then a senior exit

From May 2010 to June 2011 the share fell 2%, while the Nifty rose 4%. This was the first period in the Mars years where Cipla lagged the market. On 7 May 2010 the board approved buying two manufacturing facilities. On 9 December 2010 Joint Managing Director Amar Lulla's contract ended, and he chose not to continue.

Shani, the planet of discipline and delay, rules the 5th house of judgement and the 6th of competition and strain. It is strongest in this chart, but its sub-period brings slow, heavy work: integrating plants and handling a leadership change.

The lesson for an owner is that Cipla's growth through acquisition comes with a price in time. The share went against the chart's strong Shani here, and the flat result shows that a good planet can still bring a quiet year.

Budh's year: a small dip, cushioned by the market

Between June 2011 and June 2012 the share fell 6%, against a Nifty fall of 9%. No company event is recorded. Cipla lost less than the market, which is the best that could be said for this window.

Budh, the planet of trade and intellect, rules the 1st house of the company's identity and the 10th of its standing. It is combust, meaning scorched by the Sun, and sits in the 12th house of outflow. That explains a year of cost and caution rather than growth.

For an investor, this was a pause in which the company neither stumbled nor stretched. Cipla is a business that defends itself in a weak market. It does not need good conditions to avoid damage, and that is a sober, useful trait.

Ketu's short stretch: a 23% rise in five months

From June 2012 to November 2012 the share rose 23%, against 14% for the Nifty. No event is recorded. It was a short, sharp gain that came without any news to explain it.

Ketu, the planet of detachment, sits in the 10th house of career and standing. In this stretch it removed friction rather than adding noise, and results came quietly. The chart accounts for the lift, though not for its source.

For an owner, the lesson is that Cipla's best moves can arrive without announcements. Steady running of the business, not a headline, produced these gains. Waiting for a news trigger would have meant missing the rise.

Shukra's long year: a small gain, behind the Nifty

From November 2012 to January 2014 the share rose 5%, against 9% for the Nifty. It was a long stretch of fourteen months with little to show. No company event is recorded. The share went against the chart here, since Shukra's period was expected to be kinder.

Shukra, the planet of comfort and money, rules the 2nd house of income and the 9th of fortune. But it sits in an enemy sign in the 12th house of outflow, so what came in was largely absorbed.

The lesson for an investor is that Cipla can lag the market in a calm, rising year. Its strength is in defence and in sharp bursts, not in steady outperformance. Patience through flat spells was part of owning it.

Surya's four months: flat while the Nifty rose 10%

From January 2014 to May 2014 the share rose 0%, against 10% for the Nifty. This was the weakest relative stretch of the Mars years. No event is recorded in the four months.

Surya, the Sun, rules the 12th house of outflow and sits there in its own strong sign, with Budh and Shukra. A powerful Sun in the house of loss tends to hold gains in check, and so the share sat still while the market ran ahead.

For an owner, this reads as the pause before a push. Cipla stood still just before its best run in history. The window shows that a flat period for this company need not mean weakness underneath.

Chandra's seven months: the best run in the share's history

From May 2014 to December 2014 the share rose 64%, against 22% for the Nifty. This was the best stretch in Cipla's whole record. No event is recorded inside it, so the rise came from the business itself.

Chandra, the Moon, rules the 11th house of gains and sits in the 7th house of customers and partners. The chart's heart of gains was switched on, and the market responded to Cipla's reach. It is no surprise that this lord gave the peak.

For an investor, the lesson is that Cipla's largest gains tend to come after quiet patches, and in short bursts. Anyone who left after the flat months of early 2014 missed a move of nearly two-thirds. The business had been preparing it quietly.

Rahu's twelve years: deals and exits, then a stall

The Rahu major period, from December 2014 to November 2026, was uneven for Cipla. The share rose 135% across it, with long flat or falling spells either side of one strong run from 2020 to 2022. Rahu is the shadow planet of appetite and disruption, so this stretch was about mergers, acquisitions and changes at the top rather than steady compounding.

In this chart Rahu sits in the fourth house, the house of assets and foundations, in Dhanu. That placement explains why the company kept reshaping its base through acquisitions and restructurings. It also explains why the share often trailed the Nifty when the reshaping brought no quick earnings.

The six sub-periods below show where it paid and where it did not. In four of the six the share lagged the Nifty or only matched it. Only one, Rahu–Saturn, clearly beat it.

Three flat years while the Nifty ran ahead

From December 2014 to August 2017 the share fell 11% while the Nifty gained 17%. At its worst point inside the period the share was down 37%. No dated company event is recorded in these years, and the calendar-year figures show a mixed pattern: up 4% in 2015, down 12.2% in 2016 and up 7.4% in 2017, each behind or against the Nifty's direction.

The reason is that Rahu, in its own sub-period, amplifies its own themes. Here it holds the house of assets, and it gave Cipla restlessness without a visible reward. The chart did not favour the share in this window, and the share confirmed it.

For an investor, this stretch shows the other side of a steady pharma name. A company with a strong base can still go nowhere for nearly three years when the market is rising elsewhere. Cipla's recent operating cash of 1.02 times reported profit shows the base is sound, but the first Rahu years show that soundness alone did not move the share.

Jupiter's weak seat gave Cipla a third lost year

From August 2017 to January 2020 the share fell 13% while the Nifty rose 27%. The worst fall inside the period was 39%, the deepest of any Rahu sub-period. The calendar years bear it out: down 14.2% in 2018 and down 7.4% in 2019, while the Nifty rose both years.

Guru, the planet of expansion, rules the fourth and seventh houses here but sits in an enemy sign, and it is the weakest planet in the chart. A weak Guru gives growth that does not arrive on time. The share's fall of 40 points against the market in this window is the chart's clearest hard period in the Rahu years.

For an investor, this tells you Cipla is not a company that rewards patience in every phase. When Guru's periods run, expect expansion plans to stall and the market to move ahead without the company. The fall here also came without any dated deal or management event, so the weakness was in the business's own pace.

Shani's discipline doubled the share and beat the Nifty

From January 2020 to November 2022 the share rose 133% against 47% for the Nifty. This was the best stretch of the Rahu major period. On 29 January 2021 a Scheme of Arrangement was announced, a merger that tidied the group's structure. On 4 February 2022 the Chief Financial Officer's resignation was filed, effective in May.

Shani, the planet of discipline, is the chart's strongest working planet. It sits in its own moolatrikona sign in the sixth house and rules the fifth and sixth houses, those of skill and competition. A strong Shani rewards hard, plain work, and Cipla's year-on-year gains of 73.3% in 2020 and 15.8% in 2021 and 14.5% in 2022 fit that.

For an investor, this is the proof that Cipla's chart works when Shani leads. The company beat the market even with a change in its finance chief, which shows the business did not depend on one person during good periods. It is the benchmark against which the later, weaker sub-periods should be read.

Budh's deals kept pace with the market, no more

From November 2022 to June 2025 the share rose 39% against 38% for the Nifty, so Cipla only matched the market. Two corporate moves fell here. On 26 July 2023 the company completed an acquisition. On 26 March 2024 it merged Cipla Technologies LLC, USA with Cipla USA Inc., both wholly owned step-down subsidiaries.

Budh, the planet of trade and commerce, rules the first and tenth houses, those of the company itself and its work. But Budh is combust here, burnt by closeness to Surya, and sits in the twelfth house of losses and distant lands. That explains why the effort went into overseas structure and deal-making and showed up only partly in the share.

For an investor, this stretch shows Cipla can reorganise its American arm and add assets without a visible return to shareholders. The calendar years were uneven: up 16.8% in 2023, behind the Nifty's 20%, and up 23.7% in 2024, well ahead of its 8.8%.

Ketu's year: a chief executive leaves, the share stalls

From June 2025 to June 2026 the share fell 2% against a 4% fall for the Nifty, a small edge in a weak market. The worst point inside the period was a 28% fall. The highest close of Rs 1,648 came in October 2025, and the low of Rs 1,181 came in April 2026. On 30 March 2026 Cipla filed the resignation of Mr Umang Vohra as Managing Director and CEO, effective 1 April 2026.

Ketu, the planet of detachment, sits in the tenth house of work and authority. That placement fits a year in which leadership changed and the share went through a sharp round trip. The share beat the Nifty only narrowly, so the chart's detachment showed up as a lack of direction rather than a collapse.

For an investor, this stretch shows leadership transitions are a recurring feature here. The company filed 14 management change filings in the latest year, and its leadership record scores weakest of all the areas measured.

Shukra's months bring a court-cleared merger and a slip

From June 2026 to November 2026 the share fell 3% while the Nifty rose 5%, so Cipla lagged in a rising market. On 19 August 2026 the company received an order from the NCLT, Mumbai Bench, and on 3 September it issued notices for the merger of Inzpera Healthsciences Limited into itself.

Shukra, the planet of partnerships and comfort, rules the second and ninth houses, those of income and fortune. It sits in the twelfth house in an enemy sign. That placement fits months of deal-making, with licensing partnerships signed on 31 August and 3 September, but no gain yet in earnings or share.

For an investor, the numbers show the gap. Revenue is down 2.4% and profit down 35.1% on the year to September 2026, against 22.5% and 15.3% for the median Healthcare company. Cipla's deals have been signed ahead of the results that would justify them.

Shani and Shukra mark Cipla's mergers and exits

Cipla's named events in the record fall into a few clear groups, and the same planets keep turning up beside them. This is the pattern, drawn only from filings already made. The chart hour is not on record, so houses are indicative while the dashas are firm.

Shani, the planet of discipline and delay, sits behind the largest group. The 29 January 2021 scheme of arrangement fell in Rahu–Shani–Shukra. The 4 February 2022 resignation of the Chief Financial Officer fell in Rahu–Shani–Rahu. On 16 August 2022 the interim CFO was relieved of that added charge in Rahu–Shani–Guru. Earlier, on 7 May 2010 the board approved buying two manufacturing facilities in Mangal–Shani–Shani, and the Joint Managing Director's exit notice of 9 December 2010 came in Mangal–Shani–Surya. In this chart Shani rules the 5th and 6th houses and sits in the 6th in its own strong sign. That house deals with strain, service and structure. So Shani's sub-periods bring restructuring and changes in the finance and top team, rather than quiet growth.

Shukra, the planet of partnerships and money, is the second recurring name. The 2006 bonus issue of 3:2 on 24 April came in Chandra–Shukra–Mangal. The 2023 acquisition on 26 July came in Rahu–Budh–Shukra. The 19 August 2026 NCLT order on a merger came in Rahu–Shukra–Shukra. Shukra rules the 2nd house of wealth and the 9th of fortune here, though it sits in the 12th house of outflow and in an enemy sign. That fits what the record shows: Shukra periods bring capital moves, share-structure changes and deals, in which money is committed or restructured.

Budh and Mangal appear as a smaller pair. The 26 March 2024 merger of Cipla Technologies LLC into Cipla USA Inc. fell in Rahu–Budh–Mangal. Budh rules the 1st and 10th houses, self and career, so it ties to corporate structure. Mangal rules the 3rd and 8th, effort and sudden change, so it brings the tidying of group entities.

Ketu is the last name. The resignation of Mr Umang Vohra as Managing Director and CEO, announced 30 March 2026, fell in Rahu–Ketu–Shani. Ketu sits in the 10th house of leadership. It is the planet of detachment, and it loosens senior roles. Shani's sub-period inside it added the push.

What this tells an owner: Cipla's turning points are mostly structural, not sudden collapses. Mergers, acquisitions and top-team changes arrive when Shani and Shukra hold the sub-periods. The chart does not explain every price swing, and several of the sharpest one-day moves came without any listed event.

What Cipla's history says about its good and hard periods

Looking across ninety years of chart and eleven years of recent price record, three planets stand out. Mangal (Mars) and Chandra (the Moon) have been Cipla's best friends. Mars brought the share's strongest stretch, May 2014 to Dec 2014, when it gained 64% against 22% for the Nifty. Moon–Rahu, from May 1999 to Nov 2000, gave 127%, though it also dropped 61% along the way. Moon's whole ten years returned 1,136%. Chandra rules the house of gains here, and the record bears that out.

Rahu has been the harder teacher. Its first two stretches, Dec 2014 to Jan 2020, saw the share fall 11% and 13% while the Nifty rose 17% and 27%. Then Rahu–Shani, from Jan 2020 to Nov 2022, delivered 133%. So Rahu pays when Shani, the planet of discipline, carries it, and disappoints when it stands alone. The late Rahu stretches, Rahu–Ketu and Rahu–Venus, have been flat to slightly negative, with the share down 2% and 3% while the Nifty was down 4% in the first and up 5% in the second.

The present record agrees with that tired finish. Revenue is down 2.4% and profit down 35.1% on the year to September 2026, while the median Healthcare company grew revenue 22.5%. Return on equity of 8.2% trails peers at 12.2%. The balance sheet is the bright side: net cash of ₹1,837 crore and almost no debt. The chart's weakest planet, Guru, and the Shakata yoga, a pattern of rise and fall, fit a company whose share has moved in waves rather than straight lines.

For an owner the lesson is plain. Cipla rewards patience, has protected itself well through strain, and has never been a steady climber. The coming periods, with their dates and what each holds for the business, are read in the full reading.

Cipla does not always follow the chart, and the share lagged the Nifty in several stretches that looked supportive on paper.

Cipla: common questions

When was Cipla incorporated?

Cipla was incorporated on 17 August 1935. Its kundali is cast for that date.

What is Cipla's lagna and Moon sign?

Cipla's chart rises in Kanya, with its lord Budh in the 12th house. The Moon is in Meena, Uttara Bhadrapada pada 2.

Which dasha is Cipla running now?

Cipla is in the Rahu mahadasha and the Shukra antardasha, which runs until 28 June 2029. The sub-period inside it, Shukra, ends on 27 December 2026.

When did Cipla list on the NSE?

Cipla listed on the National Stock Exchange on 8 February 1995.

Which graha rules Cipla's sector?

Cipla is in Healthcare. In the classical scheme the sector is ruled by Ketu for research-led pharma, with Rahu for chemicals. Its strength in transit sets the sector's weather; Cipla's own chart shows how the company is built for it.

Does GrahaEdge give buy or sell calls on Cipla?

No. GrahaEdge reads the company's chart and history. It gives no share-price targets and no buy, sell or hold calls.